Results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trial
The aim of this study was to evaluate the efficacy of risperidone alone for the prevention of PEP. We initially enrolled 500 patients in the study

Related Post